DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	COLEC12; IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	53	99	53.5353535353535	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; FCN1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	59	92	64.1304347826087	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	87	161	54.0372670807453	0	0	0	0	0	0	0
up	TNFRSF13B; LILRA1; TRPA1; IFNG; IL2RA; CD3D; CD3G; CCL2; CXCR1; LAMA1; KLRC1; GLP1R; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV6-8; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	66	268	24.6268656716418	0	0	0	0	0	0	0
up	IGKV2D-30; TRAV19; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; TRAV29DV5; CD1A; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; COLEC12; TREML2; LAIR2; CLEC4G; TREML4; CD300LD; LILRB2; LILRB1; CD300LF; KIR2DL4; CD300A; SIGLEC7; BTNL8; BTNL3; BTN1A1; HHLA2;	GO:0050776~regulation of immune response	95	216	43.9814814814815	0	0	0	0	0	0	0
up	TLR9; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	53	98	54.0816326530612	0	0	0	0	0	0	0
down	EVPLL; LCE2B; FOXN1; KRT34; GJB5; KRT14; SPRR1B; SPRR2E; SPRR2D; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KLK7; BNC1; KRT31; CST6; CERS3; ACER1; SPRR2F; SPRR2G; CALML5; SPRR3; KLK5; KRTDAP;	GO:0008544~epidermis development	28	82	34.1463414634146	0	0	0	0	0	0	0
down	HOXC11; GLI2; HOXB8; HOXD10; HOXA11; HOXC8; HOXC13; HOXD13; LHX1; EMX2; ALX1; ALX4; HOXC10; HOXC5; HOXA6; HOXD9; HOXC9; HOXD4; HES2; HES7;	GO:0009952~anterior/posterior pattern specification	20	99	20.2020202020202	0	0	0	0	0	0	0
down	LCE6A; LCE2B; KRT34; KRT37; KRT75; KRT14; KRT6A; KRT6B; KRT8; KRT16; KRTAP2-3; KRT10; KRT4; CASP14; KRT9; KRT20; KRT6C; KRT76; DSG1; KRT17; KRT33B; KRT31; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE3A; LCE2A; LCE2C; LCE2D; KRT80; KRT27; ABCA12; HRNR; SPRR4; KRTAP4-1; KRTAP3-1;	GO:0031424~keratinization	39	181	21.5469613259669	0	0	0	0	0	0	0
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.00015683413804823	0.016751379602009	0.348642288881224	0.351778971642189	0.348328620605128	0.348642288881224	0.138919326702113
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00019046931489907	0.0102680276122866	0.332749893128689	0.338844911205459	0.294345940300089	0.332749893128689	0.0827736857277651
down	AKR1B15; AKR1B10; LRAT; CYP1A1; ALDH1A3; RDH12;	GO:0042572~retinol metabolic process	6	44	13.6363636363636	0.00024303723723928	0.0127165660308438	0.424343016219792	0.432363245048689	0.339669217989736	0.424343016219792	0.102512096764709
down	GLI2; FST; KRT17; KRT27; FOXQ1;	GO:0031069~hair follicle morphogenesis	5	28	17.8571428571429	0.00026596372647846	0.0135185562687199	0.464106702704928	0.473149469405196	0.359167032166273	0.464106702704928	0.108977183382441
down	OVOL1; LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	5	30	16.6666666666667	0.00035335286753113	0.0169895878739968	0.615894048106762	0.628614751337883	0.430030439785387	0.615894048106762	0.136958222204594
down	LHX1; EN1; CNTN1; CDK5R2; FAIM2; GBX2;	GO:0021549~cerebellum development	6	48	12.5	0.00037212427010568	0.0174212914873163	0.648240478524111	0.662009076518021	0.442455757155665	0.648240478524111	0.140438316003104
down	GLI2; FST; BMP5; HOXD12; LHX1;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.00040442036162369	0.0184477903417576	0.704095849586848	0.719463823328548	0.459599353922304	0.704095849586848	0.148713234691068
down	ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	3	6	50	0.00042414061025075	0.0188636536409024	0.738004661836316	0.754546145636095	0.469265224582271	0.738004661836316	0.152065634911333
down	OVOL1; CYP26A1; GLI2; WT1; LHX1; HAS2; STRA6; SIX2;	GO:0001822~kidney development	8	94	8.51063829787234	0.00046374344333854	0.0201219411146166	0.806449847965737	0.824999585699279	0.487600629070681	0.806449847965737	0.162209071979984
down	GLI2; EN2; BMP5; GBX2;	GO:0030902~hindbrain development	4	18	22.2222222222222	0.00054576004750028	0.0225792354535584	0.9485309625555	0.970907124503012	0.520849273294298	0.947985202508	0.182018067147547
down	KRT9; KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	4	18	22.2222222222222	0.00054576004750028	0.0225792354535584	0.9485309625555	0.970907124503012	0.520849273294298	0.947985202508	0.182018067147547
down	FOXN1; FST; KRT17;	GO:0051798~positive regulation of hair follicle development	3	7	42.8571428571429	0.00059796653430144	0.0241768741936878	1	1	0.542064038816572	0.999583645735023	0.19489711772818
down	ALOX12B; PSAPL1; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.00065147112132568	0.0246588749965616	1	1	0.563690993397226	0.999583645735023	0.198782672431
down	DLX2; DLX3; DLX5; DLX6;	GO:0009790~embryo development	4	19	21.0526315789474	0.00065147112132568	0.0246588749965616	1	1	0.563690993397226	0.999583645735023	0.198782672431
down	CYP26A1; LRAT; CYP1A1; GATA4;	GO:0033189~response to vitamin A	4	19	21.0526315789474	0.00065147112132568	0.0246588749965616	1	1	0.563690993397226	0.999583645735023	0.198782672431
down	HOXC11; GLI2; HOXA11; HOXD12; HOXD13; ALX4;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.00072083324910865	0.0267158822950895	1	1	0.591083264269097	0.999583645735023	0.215364832325498
up	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.00074943909304969	0.0672396754284189	1	1	0.999999999972849	0.999999999972849	0.55761917287483
down	NKX2-1; PLA2G4E; PLA2G4F; PLA2G3; PLPPR5; PLA2G2F;	GO:0006644~phospholipid metabolic process	6	57	10.5263157894737	0.00085623242088162	0.030464749534968	1	1	0.63446822387328	0.999583645735023	0.245585588488786
down	ALDH1A3; GBX2; FOXG1; DLX5; DLX6; USH1G;	GO:0042472~inner ear morphogenesis	6	57	10.5263157894737	0.00085623242088162	0.030464749534968	1	1	0.63446822387328	0.999583645735023	0.245585588488786
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0008772607889993	0.0756806134509782	1	1	0.999999999972849	0.999999999972849	0.627619940255659
down	NKX2-8; FGF1; GLI2; NKX2-1; FOXF1; STRA6; LHX3;	GO:0030324~lung development	7	80	8.75	0.00089365880290293	0.030573442507006	1	1	0.64667385617667	0.999583645735023	0.246461795511985
down	KRT6A; FGF1; REG1A; EPB41L4B; CCM2L; SPRR3; EVPLL;	GO:0042060~wound healing	7	82	8.53658536585366	0.00102237736113742	0.0343171570842163	1	1	0.685432595388534	0.999583645735023	0.276641014498274
down	GCNT3; MUC3A; MUC21; MUC15; MUCL1; MUC13;	GO:0016266~O-glycan processing	6	60	10	0.00109508240803513	0.0360768815536018	1	1	0.700782577365424	0.999583645735023	0.290826687316497
up	CCL21; TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	6	17	35.2941176470588	0.00115652914861397	0.0960775881607829	1	1	0.999999999972849	0.999999999972849	0.796772216710923
down	HOXD9; HOXD10; HOXA11; FOXL2; MST1R; DEFB126;	GO:0007338~single fertilization	6	61	9.83606557377049	0.00118507618814223	0.0376473310483041	1	1	0.719341246202334	0.999583645735023	0.303486557140986
down	GLI2; HOXA11; DMBX1; STRA6;	GO:0048589~developmental growth	4	23	17.3913043478261	0.00122095213915063	0.0381065588692803	1	1	0.7266103888508	0.999583645735023	0.307188531927794
down	HOXC11; FGF1; HOXA11;	GO:0001759~organ induction	3	10	30	0.0013698974336529	0.0385444125565874	1	1	0.757553280810054	0.999583645735023	0.310718203338546
down	BMP5; TCF15; STRA6;	GO:0043583~ear development	3	10	30	0.0013698974336529	0.0385444125565874	1	1	0.757553280810054	0.999583645735023	0.310718203338546
down	AKR1B10; LRAT; RBP1; RBP3; RDH12; STRA6;	GO:0001523~retinoid metabolic process	6	63	9.52380952380952	0.00138193709235379	0.0385444125565874	1	1	0.760065400794585	0.999583645735023	0.310718203338546
up	APOA2; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.00139925519022632	0.112090335417059	1	1	0.999999999972849	0.999999999972849	0.929566059387986
down	WT1; HOXA11; HOXD11; LHX1; ADAMTS16;	GO:0001658~branching involved in ureteric bud morphogenesis	5	42	11.9047619047619	0.0014028844724141	0.0385444125565874	1	1	0.764572037465685	0.999583645735023	0.310718203338546
down	CYP1A1; WT1; VAX1; FOXC2; STRA6;	GO:0043010~camera-type eye development	5	42	11.9047619047619	0.0014028844724141	0.0385444125565874	1	1	0.764572037465685	0.999583645735023	0.310718203338546
down	BMP5; NKX2-1; OVOL2; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	4	24	16.6666666666667	0.00140470055078579	0.0385444125565874	1	1	0.764986322398533	0.999583645735023	0.310718203338546
down	ASTN1; DSCAM; PITX3; C1QL1; NKX2-1; ALDH1A3; SLURP1;	GO:0007626~locomotory behavior	7	87	8.04597701149425	0.00140831186968982	0.0385444125565874	1	1	0.765855245263642	0.999583645735023	0.310718203338546
down	LMX1B; SPDEF; FGF1; HOXD4; EN2; FLG; HOXA11; HOXC12; TLX1; HOXD13; ALX1; PRRX2; HMX1; THEG; NKX1-2; EPHA8; FST; MST1R; SPINK6; ROS1;	GO:0007275~multicellular organism development	20	513	3.89863547758285	0.00148651132117794	0.0395429654237603	1	1	0.781904954939597	0.999583645735023	0.318767840944801
down	NKX2-1; ID4; DLX2; CDK5R2; LHX5; HSD3B1;	GO:0021766~hippocampus development	6	64	9.375	0.00148925164889935	0.0395429654237603	1	1	0.782430358784886	0.999583645735023	0.318767840944801
down	IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	4	25	16	0.0016068817788415	0.0414296041240438	1	1	0.80114711887161	0.999583645735023	0.333976607881914
down	CYP26A1; UGT1A1; CYP2C18; ALDH1A3;	GO:0042573~retinoic acid metabolic process	4	25	16	0.0016068817788415	0.0414296041240438	1	1	0.80114711887161	0.999583645735023	0.333976607881914
down	DLX5; DLX6; FOXF2; ALX1; VAX1; ALX4;	GO:0060021~roof of mouth development	6	66	9.09090909090909	0.00172279038786982	0.0437834871431487	1	1	0.818246481758637	0.999583645735023	0.352951973027034
down	PLA2G4E; PLA2G4F; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	4	26	15.3846153846154	0.00182842811283468	0.0451774112879569	1	1	0.831934791339779	0.999583645735023	0.364188818451235
down	KRT4; WT1; DLX5; DLX6; ACTL8; DLX3;	GO:0030855~epithelial cell differentiation	6	68	8.82352941176471	0.00198309664668206	0.0483277936225669	1	1	0.851056087061718	0.999583645735023	0.389585006223001
down	GLI2; NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	4	27	14.8148148148148	0.00207026415166711	0.0484605253396815	1	1	0.861229887093518	0.999583645735023	0.39065499686321
down	PLA2G4E; PLA2G4F; PLA2G2F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	4	27	14.8148148148148	0.00207026415166711	0.0484605253396815	1	1	0.861229887093518	0.999583645735023	0.39065499686321
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00210450428190756	0.162772520838574	1	1	0.999999999972849	0.999999999972849	1
down	LHX1; FAIM2; LHX5;	GO:0021702~cerebellar Purkinje cell differentiation	3	12	25	0.00212280691966416	0.0490451105205524	1	1	0.867909894971404	0.999583645735023	0.395367515359422
down	CYP1A1; CLDN18; FOXF1; ALX4;	GO:0048565~digestive tract development	4	28	14.2857142857143	0.0023333051954697	0.0532173069582129	1	1	0.892477386393392	0.999583645735023	0.429000856616916
down	LHX1; DLX6; STRA6;	GO:0060322~head development	3	13	23.0769230769231	0.00257859750195866	0.0580674045061323	1	1	0.921119774229125	0.999583645735023	0.468098964387887
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00282668593301094	0.211341884924785	1	1	0.999999999972849	0.999999999972849	1
down	MMP3; MMP12; MMP13;	GO:1904645~response to amyloid-beta	3	14	21.4285714285714	0.00309033925630731	0.0662375124936229	1	1	0.945643812430036	0.999583645735023	0.533960683547001
down	ALOX12B; CERS1; CERS3; ALOXE3;	GO:0046513~ceramide biosynthetic process	4	31	12.9032258064516	0.00325864102122142	0.0690133616280108	1	1	0.951523178196655	0.999583645735023	0.556337645564767
down	SLC6A15; SLC6A14; SLC6A2; SLC6A11;	GO:0006810~transport	4	32	12.5	0.00361541860370918	0.0728606868845899	1	1	0.964443716226701	0.999583645735023	0.587352101671167
down	FGF1; ADRA2C; NTF3; DYNAP;	GO:0032148~activation of protein kinase B activity	4	32	12.5	0.00361541860370918	0.0728606868845899	1	1	0.964443716226701	0.999583645735023	0.587352101671167
down	CTSV; NTF4; NTF3;	GO:0021675~nerve development	3	15	20	0.00366011236633779	0.0728606868845899	1	1	0.966154734055607	0.999583645735023	0.587352101671167
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.00366011236633779	0.0728606868845899	1	1	0.966154734055607	0.999583645735023	0.587352101671167
down	HOXA11; LHX1; FOXL2;	GO:0060065~uterus development	3	15	20	0.00366011236633779	0.0728606868845899	1	1	0.966154734055607	0.999583645735023	0.587352101671167
down	PTPRZ1; DMBX1; KLK6; ZIC2; EMX2; ZIC5; VAX1; SPINK6;	GO:0007417~central nervous system development	8	133	6.01503759398496	0.00368603812232327	0.0728606868845899	1	1	0.966735123363209	0.999583645735023	0.587352101671167
down	HOXD9; HOXA11; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	4	33	12.1212121212121	0.00399778905643888	0.0781545794659865	1	1	0.978131858857949	0.999583645735023	0.630027775846871
down	ALOX12B; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.00428983278987505	0.0793763689456985	1	1	0.986661541671261	0.999583645735023	0.639876991512999
down	GLI2; FOXF2; STRA6;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.00428983278987505	0.0793763689456985	1	1	0.986661541671261	0.999583645735023	0.639876991512999
down	LIPK; LIPM; PLA2G2F; PLA2G3; PNLIPRP3; LIPG;	GO:0016042~lipid catabolic process	6	81	7.40740740740741	0.00446185322910053	0.0793763689456985	1	1	0.991035269019006	0.999583645735023	0.639876991512999
up	CCL21; FFAR3; NCR3; IL18RAP; LY86; ORM1; CCL2; FOLR2; AZU1; CRHBP; CD40LG; FCGR2B; CNR2; CXCR3; AIF1; NLRP6; MS4A2; FUT7; NAIP; IL27; PLD4; CD180; PROK2; TLR9; STAB1; PF4; PTGDR; ACKR1; CCL23; PF4V1; CCR5; FPR3; CCR2; GGT5; XCL2; IL2RA;	GO:0006954~inflammatory response	36	381	9.44881889763779	0.0044688876643213	0.32265888300515	1	1	0.999999999972849	0.999999999972849	1
down	PITX3; ZIC2; GLI2; WT1; PAX3; HOXA11; GATA4; NKX2-1; LHX1; LHX2; DLX5; FOXL2; FOXF1; FOXF2; ALX1; GDF6; FOXC2; SOST; LHX3; FOXA2;	GO:0045893~positive regulation of transcription, DNA-templated	20	570	3.50877192982456	0.00466126778910581	0.0821029247209824	1	1	0.995616763191117	0.999583645735023	0.66185658480826
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00474709903663395	0.32265888300515	1	1	0.999999999972849	0.999999999972849	1
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00474709903663395	0.32265888300515	1	1	0.999999999972849	0.999999999972849	1
down	DLX3; GLI2; FST; DLX2; AMTN;	GO:0042475~odontogenesis of dentin-containing tooth	5	57	8.7719298245614	0.004767498424054	0.083150781337177	1	1	0.995728600084897	0.999583645735023	0.670303674893299
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0048426160723174	0.0836409125500257	1	1	0.995798320841117	0.999583645735023	0.674254771297555
up	PF4; IL10; IRF8; IRF4; BATF; GBP7;	GO:0042832~defense response to protozoan	6	24	25	0.00491196946686023	0.324045515122574	1	1	0.999999999972849	0.999999999972849	1
down	KRT6A; KRT16; SERPINB5;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.00498125868334987	0.0852082615161482	1	1	0.995944068753618	0.999583645735023	0.686889646820515
up	LTF; SEMG1; CTSG; RNASE3; DEFA4; BPI; AZU1; DEFA3; RNASE6;	GO:0019730~antimicrobial humoral response	9	52	17.3076923076923	0.00545445126738331	0.349552405506879	1	1	0.999999999972849	0.999999999972849	1
down	LHX2; DLX2; NR2E1;	GO:0021772~olfactory bulb development	3	18	16.6666666666667	0.00573599662877244	0.0927222955119061	1	1	0.996692466030716	0.999583645735023	0.747462554490569
down	PLA2G4F; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	3	18	16.6666666666667	0.00573599662877244	0.0927222955119061	1	1	0.996692466030716	0.999583645735023	0.747462554490569
down	FOXF1; OVOL2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.00573599662877244	0.0927222955119061	1	1	0.996692466030716	0.999583645735023	0.747462554490569
down	BMP5; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	3	18	16.6666666666667	0.00573599662877244	0.0927222955119061	1	1	0.996692466030716	0.999583645735023	0.747462554490569
down	EPCAM; WT1; LHX1; FOXC2;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.00579955343916683	0.0927222955119061	1	1	0.996759461558445	0.999583645735023	0.747462554490569
down	FOXN1; HOXC13; LHX2; ALX4;	GO:0001942~hair follicle development	4	37	10.8108108108108	0.00579955343916683	0.0927222955119061	1	1	0.996759461558445	0.999583645735023	0.747462554490569
down	WT1; BMP5; HOXD13;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.0065555076679138	0.0963822160431293	1	1	0.99748385070202	0.999583645735023	0.776966284250466
down	PLA2G4E; PLA2G4F; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.0065555076679138	0.0963822160431293	1	1	0.99748385070202	0.999583645735023	0.776966284250466
down	HOXD10; STRA6; HOXC10;	GO:0050905~neuromuscular process	3	19	15.7894736842105	0.0065555076679138	0.0963822160431293	1	1	0.99748385070202	0.999583645735023	0.776966284250466
up	LILRA5; ORM1; LPL; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	7	35	20	0.00699801967285762	0.436015503506101	1	1	0.999999999972849	0.999999999972849	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00728977740381831	0.441918127480121	1	1	0.999999999972849	0.999999999972849	1
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.0074411131498765	0.108077352191348	1	1	0.998359604741267	0.999583645735023	0.871244324846863
up	IFNG; C1QA; AZU1; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	6	27	22.2222222222222	0.00797586286672358	0.458714369488743	1	1	0.999999999972849	0.999999999972849	1
up	SLIT3; ADRA2A; CYP11B1; AIF1; AVPR2; RAMP3; GPR150; AVPR1A;	GO:0032870~cellular response to hormone stimulus	8	46	17.3913043478261	0.00836566630380764	0.469104737986013	1	1	0.999999999972849	0.999999999972849	1
down	PLA2G4E; PLA2G4F; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	3	21	14.2857142857143	0.00839400039647087	0.112277644400915	1	1	0.999291779909092	0.999583645735023	0.905104154645474
down	GLI2; WT1; ID1; ISL1; IRX4; FOXF1; FOXC2; STRA6; POPDC3;	GO:0007507~heart development	9	190	4.73684210526316	0.00923682490441602	0.122629190335493	1	1	0.999583645735023	0.999583645735023	0.988551106907273
up	HBA1; HBG2; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.00924860508279324	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
up	LTF; GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.00933454193269101	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
up	TRPM2; GATA1; FLT3; LILRB1;	GO:0097028~dendritic cell differentiation	4	12	33.3333333333333	0.00933454193269101	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
down	PITX3; CYP1A1; GAL;	GO:0035902~response to immobilization stress	3	22	13.6363636363636	0.00941522819038532	0.123159492284526	1	1	0.999583645735023	0.999583645735023	0.992826031803024
down	KRT16; KRT6C; EVPLL;	GO:0045104~intermediate filament cytoskeleton organization	3	22	13.6363636363636	0.00941522819038532	0.123159492284526	1	1	0.999583645735023	0.999583645735023	0.992826031803024
down	GABRD; CLDN17; FXYD3; ANO4; SLC26A9; SLC26A10;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.00998952270594256	0.125495604353516	1	1	0.999583645735023	0.999583645735023	1
down	GBX2; ISL1; ALX1; OVOL2;	GO:0001755~neural crest cell migration	4	44	9.09090909090909	0.0101169877713637	0.125495604353516	1	1	0.999583645735023	0.999583645735023	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0104960357112331	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0104960357112331	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0104960357112331	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0104960357112331	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
down	UGT1A1; ISL1; SSTR5;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.0105057320914976	0.127140798576696	1	1	0.999583645735023	0.999583645735023	1
up	ORM1; BPI; IL10; NCKAP1L; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	6	29	20.6896551724138	0.0106598458120533	0.477529441481607	1	1	0.999999999972849	0.999999999972849	1
down	CYP1A1; GLI2; FOXF1; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	4	45	8.88888888888889	0.0108656750152112	0.130608350351761	1	1	0.999583645735023	0.999583645735023	1
down	TCF15; FOXF1; FOXC2; HES7;	GO:0001756~somitogenesis	4	46	8.69565217391304	0.0116491682478809	0.137446359817988	1	1	0.999583645735023	0.999583645735023	1
down	CYP26A1; LRAT; TRIML2; RXRG;	GO:0032526~response to retinoic acid	4	46	8.69565217391304	0.0116491682478809	0.137446359817988	1	1	0.999583645735023	0.999583645735023	1
down	PLA2G4F; PLA2G2F; PLA2G3;	GO:0050482~arachidonic acid secretion	3	24	12.5	0.0116663295854503	0.137446359817988	1	1	0.999583645735023	0.999583645735023	1
up	JCHAIN; IGKV3-20; IGHA2; MCAM;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.0116895344741015	0.50422357356557	1	1	0.999999999972849	0.999999999972849	1
down	PITX3; GLI2; EN2; EN1;	GO:0048666~neuron development	4	47	8.51063829787234	0.0124680172757355	0.143272165686022	1	1	0.999583645735023	0.999583645735023	1
down	PITX3; CLDN1; KRT14; CYP1A1; KRT16; MMP7; FOXG1; KRT33B;	GO:0007568~aging	8	166	4.81927710843374	0.0125026184432183	0.143272165686022	1	1	0.999583645735023	0.999583645735023	1
up	SPTA1; HLA-DMB; CD40LG; AIF1; NCKAP1L; CLECL1; LILRB2; CD209; CD80;	GO:0042102~positive regulation of T cell proliferation	9	61	14.7540983606557	0.0132584683569311	0.550262882437366	1	1	0.999999999972849	0.999999999972849	1
down	BMP5; GDF6; INHBE; INHA;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.0133227475603862	0.149063949119038	1	1	0.999583645735023	0.999583645735023	1
down	KRT76; EN1; TYRP1;	GO:0043473~pigmentation	3	26	11.5384615384615	0.014200514680152	0.157891972599941	1	1	0.999583645735023	0.999583645735023	1
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.0143940061090522	0.550262882437366	1	1	0.999999999972849	0.999999999972849	1
up	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.0143940061090522	0.550262882437366	1	1	0.999999999972849	0.999999999972849	1
up	BPI; IL10; TLR9;	GO:0032717~negative regulation of interleukin-8 production	3	7	42.8571428571429	0.0143946559345374	0.550262882437366	1	1	0.999999999972849	0.999999999972849	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.0143946559345374	0.550262882437366	1	1	0.999999999972849	0.999999999972849	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0143946559345374	0.550262882437366	1	1	0.999999999972849	0.999999999972849	1
down	SCNN1G; FXYD3; SLC5A12; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	5	77	6.49350649350649	0.0151063516983239	0.159922004034047	1	1	0.999583645735023	0.999583645735023	1
down	NR2E1; HNF4G; SIX2; RXRG;	GO:0048856~anatomical structure development	4	50	8	0.0151418312282758	0.159922004034047	1	1	0.999583645735023	0.999583645735023	1
down	NTF3; ARTN; NTF4;	GO:0007422~peripheral nervous system development	3	27	11.1111111111111	0.015575190965364	0.161094562368503	1	1	0.999583645735023	0.999583645735023	1
down	DEFB4A; S100A7; LCE3A; NLRP10; DEFB126;	GO:0050829~defense response to Gram-negative bacterium	5	80	6.25	0.0174029912717517	0.178220300217125	1	1	0.999583645735023	0.999583645735023	1
up	APOA2; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	4	15	26.6666666666667	0.0174632775414674	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
up	IFNG; FCER2; CCL2; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	4	15	26.6666666666667	0.0174632775414674	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
up	IL2RA; CTLA4; IL10; CLEC4G; LILRB2; LILRB1; CD80;	GO:0042130~negative regulation of T cell proliferation	7	43	16.2790697674419	0.0178133193127488	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
down	FOXN1; PITX3; PAX3; LHX1; LHX3; EGFLAM;	GO:0009887~animal organ morphogenesis	6	111	5.40540540540541	0.0178153206523687	0.178220300217125	1	1	0.999583645735023	0.999583645735023	1
up	ABRA; GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	6	33	18.1818181818182	0.0178340294182032	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
down	GBX2; FOXC2; NRARP;	GO:0001569~branching involved in blood vessel morphogenesis	3	29	10.3448275862069	0.0185416828111686	0.178300830924697	1	1	0.999583645735023	0.999583645735023	1
down	HOXC11; HOXA11; FOXC2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.0185416828111686	0.178300830924697	1	1	0.999583645735023	0.999583645735023	1
down	PITX3; EN2; EN1;	GO:0030901~midbrain development	3	29	10.3448275862069	0.0185416828111686	0.178300830924697	1	1	0.999583645735023	0.999583645735023	1
up	PF4; IL10; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	5	24	20.8333333333333	0.0187874681886507	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
up	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0190034628042515	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
up	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.0190034628042515	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
up	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.0190034628042515	0.551412101730592	1	1	0.999999999972849	0.999999999972849	1
up	CCL21; SIGLEC6; POMC; TSHB; C1QA; WNT1; GATA1; SSTR3; FASLG; CCR5; CCL23; CRB1; GRAP; LILRB2; FCRL2; IL26; STAB1; SIRPG; ADRA1D; ADRA2A; FGFBP2; DRD3;	GO:0007267~cell-cell signaling	22	230	9.56521739130435	0.0199055720288203	0.565167064058783	1	1	0.999999999972849	0.999999999972849	1
down	CAPN8; CTRB2; CYP39A1;	GO:0007586~digestion	3	30	10	0.0201340055180315	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	LHX1; LHX3; EGFLAM;	GO:0008045~motor neuron axon guidance	3	30	10	0.0201340055180315	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	MMP13; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	3	30	10	0.0201340055180315	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
up	UPK3A; KCNA5; SLC12A3; SLC12A1;	GO:0055075~potassium ion homeostasis	4	16	25	0.0209102685209075	0.586271653654944	1	1	0.999999999972849	0.999999999972849	1
down	FST; ID1; DLX5; GDF6; BMP5;	GO:0030509~BMP signaling pathway	5	85	5.88235294117647	0.0217227635504552	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
up	CD300LD; IDO2; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	6	35	17.1428571428571	0.0224316320822575	0.617119501560788	1	1	0.999999999972849	0.999999999972849	1
down	BMP5; ID1; DLX5; DLX6;	GO:0050679~positive regulation of epithelial cell proliferation	4	57	7.01754385964912	0.0227045126361309	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
up	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.024330746949667	0.617119501560788	1	1	0.999999999972849	0.999999999972849	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.024330746949667	0.617119501560788	1	1	0.999999999972849	0.999999999972849	1
up	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.024330746949667	0.617119501560788	1	1	0.999999999972849	0.999999999972849	1
up	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.024330746949667	0.617119501560788	1	1	0.999999999972849	0.999999999972849	1
up	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.0245908799855798	0.617119501560788	1	1	0.999999999972849	0.999999999972849	1
down	ID4; FOXG1; ISL1; NR2E1;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.0252186241378733	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	GDF6; INHA; BMP5; INHBE;	GO:0060395~SMAD protein signal transduction	4	59	6.77966101694915	0.0252186241378733	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	HOXD8; HOXC8; TCF15;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.0253485093448622	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
up	LTF; MS4A1; CCL2; CCR2; CCR6; JCHAIN; IFNG; AIRE;	GO:0006959~humoral immune response	8	58	13.7931034482759	0.0261580351616295	0.617119501560788	1	1	0.999999999972849	0.999999999972849	1
down	NKX2-8; KRT4; ISL1; MARVELD3;	GO:0050680~negative regulation of epithelial cell proliferation	4	60	6.66666666666667	0.0265359731739356	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	OVOL1; KRT9; TCF15;	GO:0043588~skin development	3	34	8.82352941176471	0.0272323964290526	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	3	34	8.82352941176471	0.0272323964290526	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
up	LILRA5; IFNG; LPL; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	6	37	16.2162162162162	0.0277653720778613	0.638091991992484	1	1	0.999999999972849	0.999999999972849	1
up	IFNG; IL10; CLEC6A; CLEC9A; IL26;	GO:0050715~positive regulation of cytokine secretion	5	27	18.5185185185185	0.027879186453528	0.638091991992484	1	1	0.999999999972849	0.999999999972849	1
down	KLK8; NYAP1; NTF3; NTF4;	GO:0048812~neuron projection morphogenesis	4	62	6.45161290322581	0.0292923021621017	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0303765486065506	0.667986260044049	1	1	0.999999999972849	0.999999999972849	1
up	IFNG; AZU1; IL10;	GO:0045348~positive regulation of MHC class II biosynthetic process	3	10	30	0.0303765486065506	0.667986260044049	1	1	0.999999999972849	0.999999999972849	1
up	FCRL3; TLR9; SLAMF8;	GO:0045577~regulation of B cell differentiation	3	10	30	0.0303765486065506	0.667986260044049	1	1	0.999999999972849	0.999999999972849	1
up	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0303765486065506	0.667986260044049	1	1	0.999999999972849	0.999999999972849	1
up	POMC; ORM1; BPI; IL10; LILRA4; SLAMF1; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	7	49	14.2857142857143	0.0313003912771078	0.681619200335464	1	1	0.999999999972849	0.999999999972849	1
down	DEFB4A; KRT6A; LCE3A; PGLYRP4; PGLYRP3;	GO:0050830~defense response to Gram-positive bacterium	5	95	5.26315789473684	0.0323154461762446	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	DLX3; PLAC1; LHX3;	GO:0001890~placenta development	3	37	8.10810810810811	0.033318648803625	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	FXYD3; ANO4; SLC26A9;	GO:0006821~chloride transport	3	37	8.10810810810811	0.033318648803625	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	SAA1; SAA2; UGT1A1;	GO:0006953~acute-phase response	3	37	8.10810810810811	0.033318648803625	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
down	AGR2; FOXF1; EGFLAM;	GO:0010811~positive regulation of cell-substrate adhesion	3	37	8.10810810810811	0.033318648803625	0.190170590095312	1	1	0.999583645735023	0.999583645735023	1
up	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.0336110691877418	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
up	GPR65; P2RY10; DRD3; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	6	39	15.3846153846154	0.033873974160989	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
down	CLDN1; POF1B; MARVELD3;	GO:0070830~bicellular tight junction assembly	3	38	7.89473684210526	0.0354912089639335	0.190177291406138	1	1	0.999583645735023	0.999583645735023	1
up	PF4; LTF; SEMG1; RNASE3; DEFA4; DEFA3; RNASE6; PF4V1;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.0356292986503043	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
up	CCL21; AZU1; CCR6; CCR5; CXCR5; CXCR3; CXCR1; CCR2; CCR8;	GO:0060326~cell chemotaxis	9	74	12.1621621621622	0.0360376705319548	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
up	OR2A1; OR2T8; GPR25; P2RY10; CCL21; FCN1; GPR171; FFAR3; RGS13; RAMP3; UTS2; POMC; TSHB; PF4; ADRA2A; CALCB; HRH2; CXCR1; FPR3; ADRA1D; AVPR2; CXCR5; SSTR3; CNR2; DRD3; AVPR1A; CCR2; GLP1R; CXCR3; GPR15; CCR5; CCR6; CCR8; CCL23; OR2B6; NLRP6; TAS2R40; TAS2R41; TAS2R50; RGS1; PTGDR; ADGRE1; ACKR1; OR2B11; FFAR4; PIK3R6; OR52W1; OR2W3; GPR65; OR10G2; OR10AD1; OR52N4; OR56B1; OR52K2; OR52K1; OR52I1; GPR150; OR6N1; OR10AC1; OR52P1P; OR52I2; RXFP4; RXFP2; PIK3R5; F2RL3; NPY6R; P2RY13; ADGRE3; GPR88; P2RY12; NMUR1; PROK2; CYSLTR2; TAS2R13; XCL2; GNG8; GPR55; OR4D1; OR6K3; OR13A1; GPR152; CCL2;	GO:0007186~G protein-coupled receptor signaling pathway	82	1152	7.11805555555556	0.0360448738851757	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
up	CA6; TAS2R40; TAS2R41; TAS2R50; TAS2R13; RTP5;	GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste	6	40	15	0.0372289817914733	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
down	KCNK1; KCNJ4; FXYD3; KCNF1;	GO:0006813~potassium ion transport	4	68	5.88235294117647	0.0385448130913364	0.20214724757598	1	1	0.999583645735023	0.999583645735023	1
up	DBH; HRH2; ADRA1D; AVPR2; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	5	30	16.6666666666667	0.0393580512754983	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
down	GRIK2; NTF3; GRIA2; NTF4;	GO:0050804~modulation of chemical synaptic transmission	4	71	5.63380281690141	0.0437282028105694	0.205325739316902	1	1	0.999583645735023	0.999583645735023	1
up	LTF; BTNL3; HHLA2; BTN1A1; BTNL8;	GO:0001817~regulation of cytokine production	5	31	16.1290322580645	0.0437356427250646	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
up	HP; HBZ; HBD; HBG1; HBG2; HBA1; HBM; LOXHD1; CYGB;	GO:0098869~cellular oxidant detoxification	9	77	11.6883116883117	0.0437407761179697	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
up	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.0440981488006876	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
down	KRT6A; KRT6B; KRT16; KRT4; KRT76; KRT31;	GO:0007010~cytoskeleton organization	6	139	4.31654676258993	0.0441838993133639	0.205325739316902	1	1	0.999583645735023	0.999583645735023	1
up	IL10; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.0445894336907513	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0445894336907513	0.688182265653899	1	1	0.999999999972849	0.999999999972849	1
down	SERPINB3; ISL1; ALX1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	3	42	7.14285714285714	0.0448885358487844	0.205325739316902	1	1	0.999583645735023	0.999583645735023	1
down	DLX3; FOXF1; STRA6;	GO:0001568~blood vessel development	3	43	6.97674418604651	0.0474118026683494	0.205325739316902	1	1	0.999583645735023	0.999583645735023	1
down	GPNMB; VTCN1; PLA2G2F;	GO:0042130~negative regulation of T cell proliferation	3	43	6.97674418604651	0.0474118026683494	0.205325739316902	1	1	0.999583645735023	0.999583645735023	1
down	CXCL14; SAA2; SAA1; DEFB4A;	GO:0060326~cell chemotaxis	4	74	5.40540540540541	0.049283176662027	0.205325739316902	1	1	0.999583645735023	0.999583645735023	1
